Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-01-08 @ 4:12 AM
Study NCT ID:
NCT03811834
Status:
COMPLETED
Last Update Posted:
2024-02-12
First Post:
2019-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess Absolute Bioavailability (ABA) of Mobocertinib (TAK-788) and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of Carbon-14 ([14C])-Mobocertinib in Male Healthy Participants
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-11
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-18
First Submit QC Date:
None
Study First Post Date:
2019-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-10
Results First Submit QC Date:
None
Results First Post Date:
2021-07-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-08
Last Update Post Date:
2024-02-12
Last Update Post Date Type:
ACTUAL